| Title |
Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy
|
|---|---|
| Published in |
Core Evidence, April 2020
|
| DOI | 10.2147/ce.s179053 |
| Pubmed ID | |
| Authors |
Noritaka Takatsu, Takashi Hisabe, Daijiro Higashi, Toshiharu Ueki, Toshiyuki Matsui |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 50 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 14% |
| Student > Postgraduate | 5 | 10% |
| Student > Master | 4 | 8% |
| Student > Ph. D. Student | 4 | 8% |
| Researcher | 3 | 6% |
| Other | 8 | 16% |
| Unknown | 19 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 30% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
| Chemistry | 2 | 4% |
| Business, Management and Accounting | 1 | 2% |
| Immunology and Microbiology | 1 | 2% |
| Other | 7 | 14% |
| Unknown | 19 | 38% |